An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.
Clinical trial NCT03312634 · COMPLETED
Trial details
- NCT number
- NCT03312634
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2020-01-24
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.